Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Investigation of clinical endpoints for treatment-induced GERD symptom changes
2006-000926-30Phase 3Completed
- Sponsor
- Altana Pharma
- Start
- May 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of pantoprazole in gastroesophageal reflux disease (GERD), sponsored by Altana Pharma. Primary endpoint: Misclassification rate of clinical endpoints for GERD symptom changes. Started May 2006; status: completed.
02
Drugs
pantoprazole
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on 2006-000926-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000926-30.